Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 08 07 2021
accepted: 17 09 2021
pubmed: 30 9 2021
medline: 16 3 2022
entrez: 29 9 2021
Statut: ppublish

Résumé

Sleep disturbances are common non-motor symptoms of Parkinson's Disease (PD). The aim of this study was to investigate the polysomnographic correlates of sleep changes, as investigated by the Parkinson's Disease Sleep Scale-2 (PDSS-2), in a cohort of sixty-two consecutive de novo, drug naïve PD patients (71.40 ± 7.84 y/o). PDSS-2 total score showed a direct correlation with stage shifts (p = 0.008). Fragmented sleep showed an inverse correlation with sleep efficiency (p = 0.012). Insomnia symptoms showed an inverse correlation with wake after sleep onset (p = 0.005) and direct correlation with periodic leg movements (p = 0.006) and stage shift indices (p = 0.003). Motor Symptoms showed a direct correlation with Apnoea-Hypopnoea (AHI; p = 0.02) and awakenings indices (p = 0.003). Dream distressing showed a direct correlation with REM without atonia (RWA, p = 0.042) and an inverse correlation with AHI (p = 0.012). Sleep quality showed an inverse correlation with RWA (p = 0.008). PDSS-2 features are significantly correlated with polysomnography objective findings, thus further supporting its reliability to investigate sleep disturbances in PD patients.

Sections du résumé

BACKGROUND BACKGROUND
Sleep disturbances are common non-motor symptoms of Parkinson's Disease (PD).
METHODS METHODS
The aim of this study was to investigate the polysomnographic correlates of sleep changes, as investigated by the Parkinson's Disease Sleep Scale-2 (PDSS-2), in a cohort of sixty-two consecutive de novo, drug naïve PD patients (71.40 ± 7.84 y/o).
RESULTS RESULTS
PDSS-2 total score showed a direct correlation with stage shifts (p = 0.008). Fragmented sleep showed an inverse correlation with sleep efficiency (p = 0.012). Insomnia symptoms showed an inverse correlation with wake after sleep onset (p = 0.005) and direct correlation with periodic leg movements (p = 0.006) and stage shift indices (p = 0.003). Motor Symptoms showed a direct correlation with Apnoea-Hypopnoea (AHI; p = 0.02) and awakenings indices (p = 0.003). Dream distressing showed a direct correlation with REM without atonia (RWA, p = 0.042) and an inverse correlation with AHI (p = 0.012). Sleep quality showed an inverse correlation with RWA (p = 0.008).
CONCLUSION CONCLUSIONS
PDSS-2 features are significantly correlated with polysomnography objective findings, thus further supporting its reliability to investigate sleep disturbances in PD patients.

Identifiants

pubmed: 34586541
doi: 10.1007/s10072-021-05622-3
pii: 10.1007/s10072-021-05622-3
pmc: PMC8918173
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2531-2536

Subventions

Organisme : italian ministry of health, fondi per la ricerca corrente
ID : 2019/2020

Informations de copyright

© 2021. The Author(s).

Références

Zhang Y, Ren R, Sanford LD, Yang L, Zhou J, Tan L et al (2020) Sleep in Parkinson’s disease : a systematic review and meta-analysis of polysomnographic findings American Academy of Sleep Medicine. Sleep Med Rev 51:101281. https://doi.org/10.1016/j.smrv.2020.101281
doi: 10.1016/j.smrv.2020.101281 pubmed: 32135452
Schrempf W, Brandt MD, Storch A, Reichmann H (2014) Sleep disorders in Parkinson’s Disease. J Parkinsons Dis 4:211–221
doi: 10.3233/JPD-130301
Wetter TC, Collado-seidel V, Pollmächer T, Yassouridis A, Trenkwalder C, Planck M (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy Sleep. J Sleep Res Sleep Med 23:1–7
Lima MMS (2012) Sleep disturbances in Parkinson’s disease : the contribution of dopamine in REM sleep regulation q. Sleep Med Rev 17(5):367–375. https://doi.org/10.1016/j.smrv.2012.10.006
doi: 10.1016/j.smrv.2012.10.006
Sohail S, Yu L, Schneider JA, Bennett DA, Buchman AS, Lim ASP (2017) Sleep fragmentation and Parkinson’s disease pathology in older adults without Parkinson’s disease. Mov Disord 32:1729–1737
doi: 10.1002/mds.27200
Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R et al (2019) (2019) Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142:744–759
doi: 10.1093/brain/awz030
Arnaldi D, Chincarini A, Hu MT, Sonka K, Boeve B, Miyamoto T et al (2021) (2021) Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder. Brain 144:278–287
doi: 10.1093/brain/awaa365
Bugalho P, Ladeira F, Barbosa R, Marto JP, Borbinha C, da Conceição L et al (2021) (2021) Polysomnographic predictors of sleep, motor and cognitive dysfunction progression in Parkinson’s disease: a longitudinal study. Sleep Med 77:205–208. https://doi.org/10.1016/j.sleep.2020.06.020
doi: 10.1016/j.sleep.2020.06.020 pubmed: 32847743
Trenkwalder C, Kohnen R, Högl B, Metta V, Sixel-Döring F, Frauscher B et al (2011) (2011) Parkinson’s disease sleep scale-validation of the revised version PDSS-2. Mov Disord 26:644–652
doi: 10.1002/mds.23476
Latreille V, Carrier J, Lafortune M, Postuma RB, Bertrand J, Panisset M et al (2015) (2015) Neurobiology of aging sleep spindles in Parkinson’s disease may predict the development of dementia. Neurobiol Aging 36:1083–1090. https://doi.org/10.1016/j.neurobiolaging.2014.09.009
doi: 10.1016/j.neurobiolaging.2014.09.009 pubmed: 25442116
Mattioli P, Pardini M, Famà F, Girtler N, Brugnolo A, Orso B et al (2021) Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients. Eur J Nucl Med Mol Imaging 48:2834–2845
doi: 10.1007/s00259-021-05205-6
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC et al (2012) (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord Wiley Online Library 27:349–356
doi: 10.1002/mds.24893
Iber C, Ancoli-Israeli S, Chesson A, Quan SF (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. American Academy of Sleep Medicine, Westchester
Frauscher B, Iranzo A, Gaig C, Gschliesser V, Guaita M, Raffelseder V et al (2012) Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep. Oxford University Press 35:835–847
doi: 10.5665/sleep.1886
Arnaldi D, Morbelli S, Brugnolo A, Girtler N, Picco A, Ferrara M et al (2016) Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson’s disease and probable RBD. Parkinsonism Relat Disord. Elsevier 29:47–53
AASM (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
Yong MH, Fook-Chong S, Pavanni R, Lim LL, Tan EK (2011) Case control polysomnographic studies of sleep disorders in Parkinson’s disease. PLoS One 6(7):e22511
Borreguero DGE, Larrosa O, Bravo M, Jime  (2003) Parkinson’s disease and sleep. Sleep Med Rev 7(2):115–129
doi: 10.1053/smrv.2002.0229
Joy SP, Sinha S, Pal PK, Panda S, Philip M, Taly AB (2014) Alterations in Polysomnographic (PSG) profile in drug-naïve Parkinson’s disease. Ann Indian Acad Neurol 17(3):287
doi: 10.4103/0972-2327.138501
Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R et al (2005) (2005) Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord 20:1413–8

Auteurs

Beatrice Orso (B)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Francesco Famà (F)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Laura Giorgetti (L)

IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Pietro Mattioli (P)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Andrea Donniaquio (A)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Nicola Girtler (N)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Andrea Brugnolo (A)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Federico Massa (F)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Enrico Peira (E)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
National Institute of Nuclear Physics (INFN), Genoa section, Via Dodecaneso 33, 16146, Genoa, Italy.

Matteo Pardini (M)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Silvia Morbelli (S)

IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Department of Health Science (DISSAL), University of Genoa, Genoa, Italy.

Flavio Nobili (F)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Dario Arnaldi (D)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy. dario.arnaldi@gmail.com.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy. dario.arnaldi@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH